Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
27973 | 177 | 24.4 | 45% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
940 | 10386 | CHRONIC GRANULOMATOUS DISEASE//NADPH OXIDASE//FORMYL PEPTIDE RECEPTOR |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | RAT AIR POUCH MODEL | Author keyword | 1 | 50% | 1% | 2 |
2 | DRUG TARGETING INDEX | Author keyword | 1 | 33% | 2% | 3 |
3 | AIR POUCH | Author keyword | 1 | 11% | 5% | 8 |
4 | EXUDATE FLUID | Author keyword | 1 | 50% | 1% | 1 |
5 | POUCH FLUID | Author keyword | 1 | 50% | 1% | 1 |
6 | REGIONAL DELIVERY | Author keyword | 1 | 50% | 1% | 1 |
7 | SITE TARGETED | Author keyword | 1 | 50% | 1% | 1 |
8 | SITE TARGETED DELIVERY | Author keyword | 1 | 50% | 1% | 1 |
9 | SURFACE ARCHITECTONICS | Author keyword | 1 | 50% | 1% | 1 |
10 | ZYMOSAN PERITONITIS | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | RAT AIR POUCH MODEL | 1 | 50% | 1% | 2 | Search RAT+AIR+POUCH+MODEL | Search RAT+AIR+POUCH+MODEL |
2 | DRUG TARGETING INDEX | 1 | 33% | 2% | 3 | Search DRUG+TARGETING+INDEX | Search DRUG+TARGETING+INDEX |
3 | AIR POUCH | 1 | 11% | 5% | 8 | Search AIR+POUCH | Search AIR+POUCH |
4 | EXUDATE FLUID | 1 | 50% | 1% | 1 | Search EXUDATE+FLUID | Search EXUDATE+FLUID |
5 | POUCH FLUID | 1 | 50% | 1% | 1 | Search POUCH+FLUID | Search POUCH+FLUID |
6 | REGIONAL DELIVERY | 1 | 50% | 1% | 1 | Search REGIONAL+DELIVERY | Search REGIONAL+DELIVERY |
7 | SITE TARGETED | 1 | 50% | 1% | 1 | Search SITE+TARGETED | Search SITE+TARGETED |
8 | SITE TARGETED DELIVERY | 1 | 50% | 1% | 1 | Search SITE+TARGETED+DELIVERY | Search SITE+TARGETED+DELIVERY |
9 | SURFACE ARCHITECTONICS | 1 | 50% | 1% | 1 | Search SURFACE+ARCHITECTONICS | Search SURFACE+ARCHITECTONICS |
10 | ZYMOSAN PERITONITIS | 1 | 50% | 1% | 1 | Search ZYMOSAN+PERITONITIS | Search ZYMOSAN+PERITONITIS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CYTOTOXIC GROUPS | 1 | 100% | 1% | 2 |
2 | AIR POUCH | 1 | 12% | 3% | 6 |
3 | FACSIMILE SYNOVIUM | 1 | 50% | 1% | 1 |
4 | PHASE NONSPECIFIC AGENTS | 1 | 50% | 1% | 1 |
5 | AIR POUCH TYPE | 0 | 33% | 1% | 1 |
6 | INTERLEUKIN 1 IL 1 PRODUCTION | 0 | 33% | 1% | 1 |
7 | INDUCED CARTILAGE DEGRADATION | 0 | 20% | 1% | 1 |
8 | DIFFERENT ACTIVATION | 0 | 13% | 1% | 1 |
9 | RAT AIR POUCH | 0 | 13% | 1% | 1 |
10 | GRANULOMA POUCH | 0 | 11% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
ANALYSIS OF THE EFFECTS OF CYCLOOXYGENASE AND LIPOXYGENASE INHIBITORS ON LEUKOCYTE ACCUMULATION IN THE INFLAMMATORY SITE | 1989 | 0 | 7 | 86% |
THE CHANGING PHILOSOPHY IN THE SEARCH FOR ANTI-RHEUMATIC DRUGS - A PERSONAL OVERVIEW | 1989 | 1 | 11 | 64% |
Design of a drug delivery system for targeting based on pharmacokinetic consideration | 1996 | 21 | 56 | 11% |
ANALYSIS OF CHEMICAL MEDIATORS IN INFLAMMATORY REACTIONS AND THE MECHANISM OF ANTI-INFLAMMATORY DRUGS | 1988 | 0 | 29 | 52% |
Nanotechnology and site-targeted drug delivery | 2006 | 9 | 38 | 8% |
Essential properties of drug-targeting delivery systems | 2005 | 53 | 32 | 6% |
Subcellular drug targeting, pharmacokinetics and bioavailability | 2014 | 1 | 218 | 1% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BIOMED C13 | 0 | 20% | 0.6% | 1 |
2 | BIOSCI EXPT MED | 0 | 100% | 0.6% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000237419 | MNCF//NEUTROPHIL MIGRATION INHIBITION//NEUTROPHIL RECRUITMENT INHIBITORY FACTOR |
2 | 0.0000197271 | RHEUMATOID SYNOVIAL FLUID//ANTICHONDROCYTE IMMUNOLOGICAL RESPONSE//CARTILAGE SYNTHESIS |
3 | 0.0000132586 | MERBARONE//SEZ CHIM FARMACO PRODOTTO COSMET//SQUAMOUS CELL CARCINOMA CERVIX |
4 | 0.0000107342 | MONOSODIUM URATE MONOHYDRATE//MONOSODIUM URATE CRYSTALS//MSU CRYSTALS |
5 | 0.0000102790 | CX 659S//EARLY TYPE HYPERSENSITIVITY//BIPHASIC CUTANEOUS REACTION |
6 | 0.0000100604 | BENZYDAMINE//MED GEN SISTEMAT 3//CAS 132 69 4 |
7 | 0.0000097743 | BENZOYLOXY BENZOPHENONE//POST STUDIES BIOTECHNOL BIOINFO//YUVARAJA |
8 | 0.0000092094 | 5 OXO ETE//CLAUDE PEPPER//5 HETE |
9 | 0.0000089400 | CARRAGEENAN INDUCED GRANULOMA//COPPER ACETYLSALICYLATE//CHRONIC INFLAMMATORY JOINT DISEASE |
10 | 0.0000082873 | T KININOGEN//T KININ//M 5011 |